HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 45, Issue 1, 1997, Pages 15-20

  Bergman, H ^a   Chertkow, H ^a,b   Wolfson, C ^a,b   Stern, J ^b   Rush, C ^b   Whitehead, V ^c   Dixon, R ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031021359     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb00972.x     Document Type: Article

References (43)

1. Canadian Study of Health and Aging Workgroup. Canadian Study of Health and Aging: Study methods and prevalence of dementia. Can Med Assoc J 1994;150:899-913.
2. Joachim CL, Morris J, Selkoe DJ. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases. Ann Neurol 1988;24:50-56.
3. Katzman R, Lasker B, Benstein N. Advances in the diagnosis of dementia: Accuracy of diagnosis and consequences of misdiagnosis of disorders causing dementia. In: Terry RD, ed. Aging and the Brain, Vol. 32. New York: Raven Press, 1988, pp 17-62.
4. Berg L, Morris JC. Diagnosis. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer Disease. New York: Raven Press, 1994, pp 9-25.
5. Schecter MT. Evaluation of the diagnostic process. In: Troidl H, Spitzer WO, McPeek B, Mulder DS, McKneally MF, eds. Principles and Practices of Research: Strategies for Surgical Investigations. New York: Springer-Verlag, 1986.
6. Frackowiak RSJ, Pozzilli C, Legg NJ et al. Regional cerebral oxygen supply and utilization in dementia: A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981;104:753-778.
7. 18]fluorodeoxglucose. J Comp Assist Tomogr 1983;7:590-598.
8. Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, DiChiron G. Alzheimer's disease: Focal cortical changes shown by positron emission tomography. Neurology 1983;33:961-965.
9. Cutler NR, Haxby JV, Duara R et al. Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol 1985;18:298-309.
10. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: A prospective study using Technetium-99-HMPAO SPECT. J Nucl Med 1992;33:181-185.
11. Burns A, Philpot MP, Costa DC, Ell PJ, Levy R. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 1987;52:248-253.
12. O'Brien JT, Eagger S, Syed GMS, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:1182-1187.
13. Claus JJ, Van Horskamp F, Breteler MMB, Brenning ED et al. The diagnostic value of SPECT with Tc99 m HMPAO in Alzheimer's disease: A population based study. Neurology 1994;44:454-461.
14. Schmitt F, Shih WJ, De Kosky ST. Neuropsychological correlates of single photon emission computed tomography (SPECT) in Alzheimer's disease. Neuropsychology 1992;6:159-171.
15. Launes J, Sulkava R, Erkinjuntti T et al. Tc-99 m HMPAO SPECT in suspected dementia. Nucl Med Commun 1991;12:757-765.
16. Bonte JF, Tinter R, Weiner MF, Bigio EH, White CL. Brain blood flow in the dementias: SPECT with histopathological correlation. Radiology 1993;186:361-365.
17. Weinstein HC, Hoan J, Van Royer EO, Derix MMA, Lanser JBK et al. SPECT in the diagnosis of Alzheimer's disease and multi-infarct dementia. Clin Neurol Neurosurg 1991;93:39-43.
18. Johnson KA, Kijewski MF, Becker A, Garada B, Satlin A, Holman BL. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 1993;34:2044-2048.
19. 99mTc-HM-PAO in the routine evaluation of Alzheimer's disease. Can J Neurol Sci 1991;18:59-62.
20. Powers WJ, Perlmutter JS, Videen TO et al. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease. Neurology 1992;42:765-770.
21. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation, 1987.
22. Satz P, Mogel S. An abbreviation of the WAIS for clinical use. J Clin Psychol 1962;18:77-79.
23. Knopman D, Ryberg S. A verbal memory test with high predictive accuracy for dementia of the Alzheimer's type. Arch Neurol 1989;46:141-145.
24. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
25. Mack WJ, Freed DM, Williams BW, Henderson VW. Boston Naming Test: Shortened versions for use in Alzheimer's disease. J Gerontol 1992;3:P154-158.
26. Cole MG, Dastoor DP, Koszycki D. The hierachic dementia scale. J Clin Exp Gerontol 1983;5:219-234.
27. Folstein M, Folstein S, McHugh P. Mini-mental state - A practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 1975;12:189-198.
28. Reitan RN, Wolfson D. The Halstead-Reitan neuropsychological test battery. Tucson, AZ: Neuropsychology Press, 1985.
29. Thurstone LL, Thurstone TG. Primary mental abilitities. Psychometric monographs, No.1. Chicago: University of Chicago Press, 1938.
30. Chertkow H, Bub D. Semantic memory loss in dementia of Alzheimer's type: What do various measures measure? Brain 1990;113:397-417.
31. Tuokko H, Hadjistavropoulos T, Miller JA, Beattie BL. The clock test: A sensitive measure to differentiate normal elderly from those with Alzheimer's disease. J Am Geriatr Soc 1992;40:579-584.
32. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression rating scale: A preliminary report. J Psychiatr Res 1983;17:37-49.
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
34. Levy R. Aging-associated cognitive decline. Report, Working Party of the International Psychogeriatric Association in collaboration with World Health Organization. Int Psychogeriatr 1994;6:63-68.
35. Hachinski VC, Iliff LD, Zihka E et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
36. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1979;7:486-488.
37. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
38. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987;44:258-262.
39. Neary D, Snowden JS, Shields RA et al. Single photon emission tomography using 99 mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101-1109.
40. Testa HJ, Snowden JS, Neary D, Shields RA, Burgam AWI et al. The use of 99 mTc-HM-PAO in the diagnosis of primary degenerative dementia. J Cereb Blood Flow Metab 1988;8:S123-126.
41. Osimani A, Ichise M, Chung D-G, Pogue JM, Freedman M. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment. Can J Neurol Sci 1994;21:104-111.
42. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia: Methodological, pathophysiological and diagnostic tests. Cerebrovasc Brain Metab Rev 1995;7:89-130.
43. Jobst KA, Hindley NJ, King E, Smith AD. The diagnosis of Alzheimer's disease: A question of image. J Clin Psychiatry 1994;55:22-31.